- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.04. | European prosecutors take over investigation into deal for Pfizer COVID vaccines: Politico | ||
| 01.04. | AstraZeneca CEO's 2024 pay proposal under fire from influential proxy advisers | ||
| 01.04. | AstraZeneca's rare disease add-on therapy Voydeya scores FDA nod | ||
| 01.04. | Teva snares up to $150M in Abingworth funding to propel late-stage asthma rescue inhaler | ||
| 01.04. | Eisai, Biogen's injectable Leqembi delayed as FDA asks for more data | ||
| 01.04. | 'Saturday Night Live' sends up Ozempic craze in Ramadan-themed parody ad | ||
| 29.03. | 'Unprecedented' demand for Eli Lilly's Zepbound sparks US supply constraints | ||
| 29.03. | Teva, following Hikma complaint, alleges Amarin 'locked up' Vascepa ingredient to block generics | ||
| 29.03. | Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis | ||
| 29.03. | J&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti | ||
| 29.03. | After Amgen's stumble, BMS touts KRAS confirmatory trial win for newly bought Krazati | ||
| 29.03. | Old tweet, new problem: PMCPA chides Pfizer over UK staffer's 2020 Twitter misstep | ||
| 29.03. | Bristol Myers Squibb's versatile Zeposia doesn't make the grade in Crohn's disease trial | ||
| 28.03. | Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly | ||
| 28.03. | Amneal pulls 4 lots of antibiotic vancomycin due to potentially overfilled, extra-potent bottles | ||
| 28.03. | Johnson & Johnson gets a new opportunity to contest science in talc litigation | ||
| 28.03. | Pfizer shifts creative business to Publicis in latest marketing move | ||
| 28.03. | Intelligence officials warned lawmakers WuXi AppTec furnished China with client's intellectual property: Reuters | ||
| 28.03. | Abzena earmarks $5M to bolster ADC, complex biologic services at Pennsylvania site | ||
| 27.03. | WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US | ||
| 27.03. | AstraZeneca plans independent drug supply chains for US and China, CEO says | ||
| 27.03. | Olympus mounts lung cancer education push with advocacy group | ||
| 27.03. | NHS says Kate Middleton's cancer announcement sent symptom searches skyrocketing | ||
| 27.03. | Sanofi inks 3 distribution pacts in India and Korea for CNS drugs and vaccines | ||
| 27.03. | More revamp at Bayer as it axes 90 at its U.S. headquarters in New Jersey |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
